Home »
Academic Articles »
C »
Lost to follow up?: A qualitative study of why some patients do not pursue lung cancer screening
Lost to follow up?: A qualitative study of why some patients do not pursue lung cancer screening
Ilana B. Richman
(Section of General Internal Medicine, Yale School of Medicine, New Haven, CT, United States; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine, New Haven, CT, United States; Corresponding author at: 367 Cedar St., New Haven, CT 06510, United States.)
Taara V. Prasad
(Palliative and Advanced Illness Research (PAIR) Center, University of Pennsylvania School of Medicine, Philadelphia, PA, United States)
Cary P. Gross
(Section of General Internal Medicine, Yale School of Medicine, New Haven, CT, United States; Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale School of Medicine, New Haven, CT, United States)
Journal: Preventive Medicine Reports
•
• Elsevier
• ISSN: 2211-3355
Abstract
Although national guidelines recommend lung cancer screening for adults at high risk, only a small proportion of eligible adults in the US have been screened. The goal of this study was to understand barriers to screening among a specific but important population: patients who have been referred for screening, but who have not completed the test. We used semi-structured interviews to explore barriers to screening among patients at two academic, safety-net primary care practices. We included patients who had been referred for screening at least 6 months prior but who had not completed the test. Among interviewees (N = 16) a consistent theme was a lack of knowledge about the purpose and process of screening. Despite being referred for lung cancer screening, participants expressed that they knew little about how screening was performed or what it was intended to achieve. Preferences and values also played a role in why some participants did not return for screening. Our findings suggest that lack of knowledge about screening is an important barrier to use, as patients are unlikely to prioritize a test if they know little about it.
Ilana B. Richman, Taara V. Prasad, Cary P. Gross (2022). "Lost to follow up?: A qualitative study of why some patients do not pursue lung cancer screening". Preventive Medicine Reports. https://doi.org/10.1016/j.pmedr.2022.101909